Comparison between ESDS Software Solution IPO and Supriya Lifescience IPO.
ESDS Software Solution IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of ESDS Software Solution IPO is up to ₹0.00 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of ESDS Software Solution IPO is and of Supriya Lifescience IPO is ₹274.00 per share.
| ESDS Software Solution IPO | Supriya Lifescience IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹2 per share |
| Issue Price (Lower) | ₹265.00 per share | |
| Issue Price (Upper) | ₹274.00 per share | |
| Issue Price (Final) | ₹274.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 54 shares | |
| Fresh Issue Size | 0 shares | 72,99,270 shares |
| Fresh Issue Size (Amount) | up to ₹600.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 0 shares | 1,82,48,175 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹500.00 Cr |
| Issue Size Total | 0 shares | 2,55,47,445 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹700.00 Cr |
ESDS Software Solution IPO opens on , while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of ESDS Software Solution IPO and Supriya Lifescience IPO is , and Dec 20, 2021, respectively.
| ESDS Software Solution IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | Dec 15, 2021 | |
| Issue Open | Dec 16, 2021 | |
| Issue Close | Dec 20, 2021 | |
| Basis Of Allotment (Tentative) | Dec 23, 2021 | |
| Initiation of Refunds (Tentative) | Dec 24, 2021 | |
| Credit of Share (Tentative) | Dec 27, 2021 | |
| Listing date (Tentative) | Dec 28, 2021 | |
| Anchor Lockin End date 1 | Jan 22, 2022 | |
| Anchor Lockin End date 2 | Mar 23, 2022 |
ESDS Software Solution IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
| ESDS Software Solution IPO | Supriya Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials ()
| ||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 46.06 | 99.98 | ||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.24 | |||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹700.00 Cr. | |||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.23% | |||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.53% | |||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.36 | |||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.60% | |||||||||||||||||||||||||||||||||||||||||||
In the ESDS Software Solution IPO Retail Individual Investors (RII) are offered while in Supriya Lifescience IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in ESDS Software Solution IPO and 76,64,234 shares in Supriya Lifescience IPO.
| ESDS Software Solution IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,14,96,351 shares | |
| Market Maker Reservation | ||
| QIB | 76,64,234 shares | |
| NII | 38,32,116 shares | |
| RII | 25,54,744 shares | |
| Employee | ||
| Others | ||
| Total | 2,55,47,445 shares |
ESDS Software Solution IPO subscribed in total, whereas Supriya Lifescience IPO subscribed 71.51x.
| ESDS Software Solution IPO | Supriya Lifescience IPO | |
|---|---|---|
| QIB (times) | 31.83x | |
| NII (times) | 161.22x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 56.01x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 71.51x |
